The Distribution of Sales Revenues from Pharmaceutical Innovation
- 1 January 2000
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 18 (1), 21-32
- https://doi.org/10.2165/00019053-200018001-00005
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The determinants of pharmaceutical research and development expendituresJournal of Evolutionary Economics, 2000
- Uncertainty and the size distribution of rewards from innovationJournal of Evolutionary Economics, 2000
- Effective patent life in pharmaceuticalsInternational Journal of Technology Management, 2000
- Longer Patents for Increased Generic Competition in the USPharmacoEconomics, 1996
- Success rates for new drugs entering clinical testing in the United StatesClinical Pharmacology & Therapeutics, 1995
- Innovation and Structural Change in Pharmaceuticals and BiotechnologyIndustrial and Corporate Change, 1994
- Returns to R&D on new drug introductions in the 1980sJournal of Health Economics, 1994
- Cost of innovation in the pharmaceutical industryJournal of Health Economics, 1991
- The structure and governance of venture-capital organizationsJournal of Financial Economics, 1990
- A New Look at the Returns and Risks to Pharmaceutical R&DManagement Science, 1990